<?xml version="1.0" encoding="UTF-8"?>
<p>Another important progressive biomarker of AD is the serum amyloid P component (SAP) which is produced in the liver and localized in the brain. SAP is a neurotoxic agent that, through binding to fibrils, protects Aβ from proteolysis. With disease progression, more cytokines and acute-phase proteins are released and, thus, more Aβ fibrils will be deposited (
 <xref rid="B57" ref-type="bibr">57</xref>, 
 <xref rid="B58" ref-type="bibr">58</xref>). 
</p>
